The filing signals an officer's intent to sell a meaningful block of shares following an option exercise. Monitor for the actual sale on Form 4 and any subsequent insider selling patterns, as this is a large increase from the recent insider sale activity.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $247.06entry
- T+1 · 13d ago +3.49%α +1.84% · $255.68
- T+5 · 7d ago +4.61%α +5.19% · $258.44
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Catherine T. Doherty, an officer of Quest Diagnostics, filed a Form 144 notice of intent to sell 22,105 shares of common stock, valued at approximately $5.58 million based on the filing date. The shares were acquired through a stock option exercise on the same day. The sale is a routine insider transaction following option exercise, but the size is notable relative to recent insider activity.
Key Facts
- Reporting owner: Catherine T. Doherty, an officer of Quest Diagnostics
- Proposed sale: 22,105 shares of common stock
- Approximate value: $5,584,607.20 (based on filing date price)
- Shares acquired via stock option exercise on 11/03/2026
- Broker: Fidelity Brokerage Services LLC
- Sale intended to be executed on or after 11/03/2026 on NYSE
- Recent insider activity (30 days): 1 sell totaling $292K, making this sale ~19x larger
Financial Impact
Proposed sale of $5.58M in stock, representing about 0.02% of Quest Diagnostics' $27.8B market cap
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur or may be at different terms
- The sale is large relative to recent insider activity, which could signal reduced conviction or routine portfolio diversification
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007668 |
| Document: 0001959173-26-007668-index.html | 0001959173-26-007668 |
| Document: 0001959173-26-007668.txt | 0001959173-26-007668 |
Track record
24 reports on DGX
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +7.06% at T+5 after the Sep 9, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $259.60 +0.00% settles Feb 11
- Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $259.60 +0.35% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $259.60 +0.45% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $259.60 −0.03% settles Feb 5
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $259.60 −0.03% settles Feb 5
- Nov 5, 202611d ago 3 Neutral 2/10 Entry $255.63 Now $259.60 +1.55% settles Feb 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $259.60 +5.08% settles Feb 1
- Nov 3, 202613d ago 144 Neutral 3/10 Viewing Entry $247.06 Now $259.60 +5.08% settles Feb 1
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $259.60 +5.69% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers